TransCode Therapeutics Inc. Gains 31.76%
Wed, Apr 05, 2023 at 07:08 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $0.43, a gain of 31.8%. On Wed, Apr 05, 2023, RNAZ:NASDAQ touched a New 2-Week High of $0.43. The stock appeared on our News Catalysts scanner on Wed, Apr 05, 2023 at 07:43 AM in the 'BIOTECH' category. From Wed, Mar 22, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Feb 01, 2023 at $1.07 with a volume of 10M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Jowell Global Ltd. (JWEL:NASDAQ), 146.47%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 77.78%
- InflaRx N.V. (IFRX:NASDAQ), 61.8%
- Nuburu Inc. (BURU:NYSEMKT), 56.99%
- Scilex Holding Company Com (SCLX:NASDAQ), 56.57%
- Virgin Orbit Holdings Inc. (VORB:NASDAQ), 34.23%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 31.76%
- Freight Technologies Inc Com (FRGT:NASDAQ), 30.41%
- Creatd Inc. (CRTD:NASDAQ), 26.62%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 25.71%